Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 6 (2006), Pages 946-966
http://dx.doi.org/10.1100/tsw.2006.182
Review Article

Signal Transduction of Sphingosine-1-Phosphate G Protein—Coupled Receptors

1Integrated Biomedical Science Graduate Program, Ohio State University, Columbus, USA
2Department of Pathology, Ohio State University, Columbus, USA

Received 14 June 2006; Accepted 31 July 2006

Academic Editor: Markus Graeler

Copyright © 2006 Nicholas Young and James R. Van Brocklyn.

Citations to this Article [53 citations]

The following is the list of published articles that have cited the current article.

  • Andrea Huwiler, and Uwe Zangemeister-Wittke, “Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy,” Critical Reviews In Oncology Hematology, vol. 63, no. 2, pp. 150–159, 2007. View at Publisher · View at Google Scholar
  • Nicholas Young, and James R. Van Brocklyn, “Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness,” Experimental Cell Research, vol. 313, no. 8, pp. 1615–1627, 2007. View at Publisher · View at Google Scholar
  • Dyatlovitskaya, “The role of lysosphingolipids in the regulation of biological processes,” Biochemistry (Moscow), vol. 72, no. 5, pp. 479–484, 2007. View at Publisher · View at Google Scholar
  • E. V. Dyatlovitskaya, “The role of lysosphingolipids in the regulation of biological processes,” Biochemistry-Moscow, vol. 72, no. 5, pp. 479–484, 2007. View at Publisher · View at Google Scholar
  • Petra Haenel, Paul Andreani, and Markus H. Graeler, “Erythrocytes store and release sphingosine 1-phosphate in blood,” Faseb Journal, vol. 21, no. 4, pp. 1202–1209, 2007. View at Publisher · View at Google Scholar
  • Stephan L. M. Peters, and Astrid E. Alewijnse, “Sphingosine-1-phosphate signaling in the cardiovascular system,” Current Opinion in Pharmacology, vol. 7, no. 2, pp. 186–192, 2007. View at Publisher · View at Google Scholar
  • James R. Van Brocklyn, “Sphingolipid signaling pathways as potential therapeutic targets in gliomas,” Mini-Reviews in Medicinal Chemistry, vol. 7, no. 10, pp. 984–990, 2007. View at Publisher · View at Google Scholar
  • Peter Kovacic, Robert S. Pozos, and Christine D. Draskovich, “Unifying electrostatic mechanism for receptor-ligand activity,” Journal of Receptors and Signal Transduction, vol. 27, no. 5-6, pp. 411–431, 2007. View at Publisher · View at Google Scholar
  • Nicholas J. Machesky, Guojuan Zhang, Bindu Raghavan, Pete Zimmerman, Samuel L. Kelly, Alfred H. Merrill, W. James Waldman, James R. Van Brocklyn, and Joanne Trgovcich, “Human cytomegalovirus regulates bioactive sphingolipids,” Journal of Biological Chemistry, vol. 283, no. 38, pp. 26148–26160, 2008. View at Publisher · View at Google Scholar
  • Astrid E. Alewijnse, and Stephan L. M. Peters, “Sphingolipid signalling in the cardiovascular system: Good, bad or both?,” European Journal of Pharmacology, vol. 585, no. 2-3, pp. 292–302, 2008. View at Publisher · View at Google Scholar
  • D. Thusitha U. Abeytunga, Lynne Oland, Arpad Somogyi, and Robin Polt, “Structural studies on the neutral glycosphingolipids of Manduca sexta,” Bioorganic Chemistry, vol. 36, no. 2, pp. 70–76, 2008. View at Publisher · View at Google Scholar
  • Dyatlovitskaya, “Sphingolipid receptors,” Biochemistry (Moscow), vol. 73, no. 2, pp. 119–122, 2008. View at Publisher · View at Google Scholar
  • Viviana Anelli, Christopher R. Gault, Amy B. Cheng, and Lina M. Obeid, “Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells,” Journal of Biological Chemistry, vol. 283, no. 6, pp. 3365–3375, 2008. View at Publisher · View at Google Scholar
  • E. V. Dyatlovitskaya, “Sphingolipid receptors,” Biochemistry-Moscow, vol. 73, no. 2, pp. 119–122, 2008. View at Publisher · View at Google Scholar
  • Erhard Bieberich, “Smart drugs for smarter stem cells: Making SENSe (sphingolipid-enhanced neural stem cells) of ceramide,” NeuroSignals, vol. 16, no. 2-3, pp. 124–139, 2008. View at Publisher · View at Google Scholar
  • Lukasz Wator, Urszula Razny, Adriana Balwierz, Anna Polus, Hans G. Joost, Grzegorz Dyduch, Romana Tomaszewska, and Aldona Dembinska-Kiec, “Impaired leptin activity in New Zealand Obese mice: Model of angiogenesis,” Genes and Nutrition, vol. 3, no. 3-4, pp. 177–180, 2008. View at Publisher · View at Google Scholar
  • Ghotas Evindar, Alexander L. Satz, Sylvie G. Bernier, Malcolm J. Kavarana, Elisabeth Doyle, Jeanine Lorusso, Nazbeh Taghizadeh, Keith Halley, Amy Hutchings, Michael S. Kelley, Albion D. Wright, Ashis K. Saha, Gerhard Hannig, Barry A. Morgan, and William F. Westlin, “Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists,” Bioorganic & Medicinal Chemistry Letters, vol. 19, no. 8, pp. 2315–2319, 2009. View at Publisher · View at Google Scholar
  • M. Jongsma, J. van Unen, P. B. van Loenen, M. C. Michel, S. L. M. Peters, and A. E. Alewijnse, “Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)),” British Journal Of Pharmacology, vol. 156, no. 8, pp. 1305–1311, 2009. View at Publisher · View at Google Scholar
  • Satoshi Nemoto, Mitsuhiro Nakamura, Yosuke Osawa, Saki Kono, Yoshinori Itoh, Yukio Okano, Takashi Murate, Akira Hara, Hiroshi Ueda, Yoshinori Nozawa, and Yoshiko Banno, “Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation,” Journal Of Biological Chemistry, vol. 284, no. 16, pp. 10422–10432, 2009. View at Publisher · View at Google Scholar
  • Che-Chung Yeh, Hongzhe Li, Deepak Malhotra, Mei-Chuan Huang, Bo-Qing Zhu, Edward J. Goetzl, Donald A. Vessey, Joel S. Karliner, and Michael J. Mann, “Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction,” American Journal Of Physiology-Heart And Circulatory Physiology, vol. 296, no. 4, pp. H1193–H1199, 2009. View at Publisher · View at Google Scholar
  • S. -C. Sensken, and M. H. Graeler, “Sphingolipids and their medical impact,” Deutsche Medizinische Wochenschrift, vol. 134, no. 6, pp. 259–263, 2009. View at Publisher · View at Google Scholar
  • Nicholas Young, Dennis K. Pearl, and James R. Van Brocklynl, “Sphingosine-1-Phosphate Regulates Glioblastoma Cell Invasiveness through the Urokinase Plasminogen Activator System and CCN1/Cyr61,” Molecular Cancer Research, vol. 7, no. 1, pp. 23–32, 2009. View at Publisher · View at Google Scholar
  • Yuya Yoshida, Mitsutoshi Nakada, Tomoya Harada, Shingo Tanaka, Takuya Furuta, Yasuhiko Hayashi, Daisuke Kita, Naoyuki Uchiyama, Yutaka Hayashi, and Jun-ichiro Hamada, “The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients,” Journal Of Neuro-Oncology, vol. 98, no. 1, pp. 41–47, 2010. View at Publisher · View at Google Scholar
  • Mitsutoshi Nakada, Naotoshi Sugimoto, Tomoya Harada, Yasuhiko Hayashi, Daisuke Kita, Naoyuki Uchiyama, Yutaka Hayashi, Akihiro Yachie, Yoh Takuwa, Jun-ichiro Hamada, and Yuya Yoshida, “Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival,” International Journal Of Cancer, vol. 126, no. 10, pp. 2341–2352, 2010. View at Publisher · View at Google Scholar
  • Ghotas Evindar, Sylvie G. Bernier, Elisabeth Doyle, Malcolm J. Kavarana, Alexander L. Satz, Jeanine Lorusso, Heather S. Blanchette, Ashis K. Saha, Gerhard Hannig, Barry A. Morgan, and William F. Westlin, “Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 8, pp. 2520–2524, 2010. View at Publisher · View at Google Scholar
  • James R Van Brocklyn, “Regulation of cancer cell migration and invasion by sphingosine-1-phosphate,” World Journal of Biological Chemistry, vol. 1, no. 10, pp. 307, 2010. View at Publisher · View at Google Scholar
  • Dmitri Pchejetski, Torsten Böhler, Justin Stebbing, and Jonathan Waxman, “Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer,” Nature Reviews Urology, vol. 8, no. 10, pp. 569–678, 2011. View at Publisher · View at Google Scholar
  • Mirjam Schuchardt, Markus Tölle, Jasmin Prüfer, and Markus van der Giet, “Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system,” British Journal of Pharmacology, vol. 163, no. 6, pp. 1140–1162, 2011. View at Publisher · View at Google Scholar
  • Adriana Estrada-Bernal, Sean E. Lawler, Michal O. Nowicki, Abhik Ray Chaudhury, and James R. Van Brocklyn, “The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells,” Journal Of Neuro-Oncology, vol. 102, no. 3, pp. 353–366, 2011. View at Publisher · View at Google Scholar
  • Ricky Malhotra, Vesta Valuckaite, Michelle L. Staron, Tiju Theccanat, Karen M. D'Souza, John C. Alverdy, and Shahab A. Akhter, “High-molecular-weight polyethylene glycol protects cardiac myocytes from hypoxia- and reoxygenation-induced cell death and preserves ventricular function,” American Journal Of Physiology-Heart And Circulatory Physiology, vol. 300, no. 5, pp. H1733–H1742, 2011. View at Publisher · View at Google Scholar
  • Steffi Becker, Soren von Otte, Horst Robenek, Klaus Diedrich, and Jerzy-Roch Nofer, “Follicular Fluid High-Density Lipoprotein-Associated Sphingosine 1-Phosphate (S1P) Promotes Human Granulosa Lutein Cell Migration via S1P Receptor Type 3 and Small G-Protein RAC1,” Biology Of Reproduction, vol. 84, no. 3, pp. 604–612, 2011. View at Publisher · View at Google Scholar
  • Michelle E. Bradley, Neil McGuinness, Gareth Williams, Steven J. Charlton, and Mark R. Dowling, “The in vitro metabolism of sphingosine-1-phosphate: Identification; inhibition and pharmacological implications,” European Journal of Pharmacology, vol. 672, no. 1-3, pp. 56–61, 2011. View at Publisher · View at Google Scholar
  • Michael Hecker, Brigitte Katrin Paap, Robert Hermann Goertsches, Ole Kandulski, Christian Fatum, Dirk Koczan, Hans-Peter Hartung, Hans-Juergen Thiesen, and Uwe Klaus Zettl, “Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis,” Plos One, vol. 6, no. 12, 2011. View at Publisher · View at Google Scholar
  • S. Vetrano, V. A. Ploplis, E. Sala, M. Sandoval-Cooper, D. L. Donahue, C. Correale, V. Arena, A. Spinelli, A. Repici, A. Malesci, F. J. Castellino, and S. Danese, “Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation,” Proceedings of the National Academy of Sciences, vol. 108, no. 49, pp. 19830–19835, 2011. View at Publisher · View at Google Scholar
  • Sujatha Narayan, and Elizabeth A. Thomas, “Sphingolipid abnormalities in psychiatric disorders: a missing link in pathology?,” Frontiers In Bioscience-Landmark, vol. 16, pp. 1797–1810, 2011. View at Publisher · View at Google Scholar
  • James R. Van Brocklyn, and Joseph B. Williams, “The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: Oxidative stress and the seesaw of cell survival and death,” Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, vol. 163, no. 1, pp. 26–36, 2012. View at Publisher · View at Google Scholar
  • Sang W Park, Mihwa Kim, Joo Y Kim, Kevin M Brown, Volker H Haase, Vivette D D'Agati, and H Thomas Lee, “Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia,” Kidney International, vol. 82, no. 8, pp. 878–891, 2012. View at Publisher · View at Google Scholar
  • Silvia D’Alessio, Marco Genua, and Stefania Vetrano, “The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm,” Annals of the New York Academy of Sciences, vol. 1258, no. 1, pp. 78–85, 2012. View at Publisher · View at Google Scholar
  • Kenneth C. Loh, Weng-In Leong, Morgan E. Carlson, Babak Oskouian, Ashok Kumar, Henrik Fyrst, Meng Zhang, Richard L. Proia, Eric P. Hoffman, and Julie D. Saba, “Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway,” Plos One, vol. 7, no. 5, 2012. View at Publisher · View at Google Scholar
  • Daisuke Saigusa, Kanako Shiba, Asuka Inoue, Kotaro Hama, Michiyo Okutani, Nagisa Iida, Masayoshi Saito, Kaori Suzuki, Tohru Kaneko, Naoto Suzuki, Hiroaki Yamaguchi, Nariyasu Mano, Junichi Goto, Takanori Hishinuma, Junken Aoki, and Yoshihisa Tomioka, “Simultaneous quantitation of sphingoid bases and their phosphates in biological samples by liquid chromatography/electrospray ionization tandem mass spectrometry,” Analytical and Bioanalytical Chemistry, vol. 403, no. 7, pp. 1897–1905, 2012. View at Publisher · View at Google Scholar
  • Sang Won Park, Mihwa Kim, Kevin M. Brown, Vivette D. D'Agati, and H. Thomas Lee, “Inhibition of Sphingosine 1-Phosphate Receptor 2 Protects against Renal Ischemia-Reperfusion Injury,” Journal Of The American Society Of Nephrology, vol. 23, no. 2, pp. 266–280, 2012. View at Publisher · View at Google Scholar
  • Satomi Kawahara, Yoko Otsuji, Mitsuhiro Nakamura, Masashi Murakami, Takashi Murate, Toshiyuki Matsunaga, Hiroyuki Kanoh, Mariko Seishima, Yoshiko Banno, and Akira Hara, “Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells,” Anti-Cancer Drugs, vol. 24, no. 5, pp. 473–483, 2013. View at Publisher · View at Google Scholar
  • Maryam Tabasinezhad, Parisa Ghanbari, Mahsa Mohseni, Amir Ata Saei, Simin Sharifi, Nazli Saeedi, and Abolfazl Pourhassan, “Sphingosin 1-phosphate contributes in tumor progression,” Journal of Cancer Research and Therapeutics, vol. 9, no. 4, pp. 556–563, 2013. View at Publisher · View at Google Scholar
  • Ghotas Evindar, Hongfeng Deng, Sylvie G. Bernier, Elisabeth Doyle, Jeanine Lorusso, Barry A. Morgan, and William F. Westlin, “Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 2, pp. 472–475, 2013. View at Publisher · View at Google Scholar
  • Julie D. Saba, and Anabel S. de la Garza-Rodea, “S1P lyase in skeletal muscle regeneration and satellite cell activation: Exposing the hidden lyase,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1831, no. 1, pp. 167–175, 2013. View at Publisher · View at Google Scholar
  • H. Y. Pan, H. Yang, M. Y. Shao, J. Xu, P. Zhang, R. Cheng, and T. Hu, “Sphingosine-1-phosphate mediates AKT/ERK maintenance of dental pulp homoeostasis,” International Endodontic Journal, 2014. View at Publisher · View at Google Scholar
  • V Mignard, L Lalier, F Paris, and F M Vallette, “Bioactive lipids and the control of Bax pro-apoptotic activity,” Cell Death and Disease, vol. 5, no. 5, pp. e1266, 2014. View at Publisher · View at Google Scholar
  • Michiel Langeslag, Serena Quarta, Michael G. Leitner, Michaela Kress, and Norbert Mair, “Sphingosine 1-phosphate to p38 signaling via S1P(1) receptor and G alpha i/o evokes augmentation of capsaicin-induced ionic currents in mouse sensory ,” Molecular Pain, vol. 10, 2014. View at Publisher · View at Google Scholar
  • Domiziana Costamagna, Emanuele Berardi, Gabriele Ceccarelli, and Maurilio Sampaolesi, “Adult stem cells and skeletal muscle regeneration,” Current Gene Therapy, vol. 15, no. 4, pp. 348–363, 2015. View at Publisher · View at Google Scholar
  • Devadoss J. Samuvel, Nishant Saxena, Jasdeep S. Dhindsa, Avtar K. Singh, Gurmit S. Gill, Damian W. Grobelny, and Inderjit Singh, “AKP-11-A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis,” Plos One, vol. 10, no. 10, 2015. View at Publisher · View at Google Scholar
  • Olga Sukocheva, Carol Wadham, Jennifer Gamble, and Pu Xia, “Sphingosine-1-phosphate receptor 1 transmits estrogens’ effects in endothelial cells,” Steroids, 2015. View at Publisher · View at Google Scholar
  • Salina Gairhe, Sachindra R. Joshi, Mrigendra M. Bastola, Jared M. McLendon, Masahiko Oka, Karen A. Fagan, and Ivan F. McMurtry, “Sphingosine-1-Phosphate is Involved in the Occlusive Arteriopathy of Pulmonary Arterial Hypertension,” Pulmonary Circulation, vol. 6, no. 3, pp. 369–380, 2016. View at Publisher · View at Google Scholar
  • Rajeev Nema, Supriya Vishwakarma, Rahul Agarwal, Rajendra Kumar Panday, and Ashok Kumar, “Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma,” Oncotargets And Therapy, vol. 9, pp. 3269–3280, 2016. View at Publisher · View at Google Scholar